Beren Therapeutics
PrivateLast Round
VC Round
Jun 10, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Beren Therapeutics operates in Healthcare & Life Sciences and is based in Thousand Oaks, California. Its latest recorded funding round was a VC Round in June 2026.
Beren Therapeutics is a biotechnology company that develops cyclodextrin-based therapeutics for conditions characterized by defective cholesterol trafficking, such as Niemann-Pick disease type C.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beren Therapeutics Comparables
Compare Beren Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ventus Therapeutics | 84% | |
| NodThera | 81% | |
| Brenig Therapeutics | 80% |
For institutional investors. Book with your work email.
Beren Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 10, 2026 | ||||
| Corporate Funding | May 23, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Beren Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | VC Round |
| Narya Capital | VC Round |
| Gaingels | VC Round |
| Founders Fund | VC Round |
| JIC Venture Growth Investments | VC Round |
| Wellington Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 80% MoM.
- Jul 18, 2026
Grew 16% QoQ, from 93 to 108 employees.
For institutional investors. Book with your work email.
Beren Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beren Therapeutics's valuation, stock price, and market status.
Is Beren Therapeutics a public or private company?
Beren Therapeutics is a private company.
What is the current stock price of Beren Therapeutics?
Beren Therapeutics is a private company, so its shares have no public market price. Caplight tracks Beren Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beren Therapeutics worth (valuation)?
Valuation information for Beren Therapeutics is not publicly available.
Can I buy Beren Therapeutics stock?
Beren Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beren Therapeutics's last funding round?
Beren Therapeutics's most recent funding round was VC Round on June 10, 2026.
Who are the main investors in Beren Therapeutics?
Key investors in Beren Therapeutics include Hercules Capital.
Will Beren Therapeutics IPO soon?
No public IPO plans have been announced for Beren Therapeutics.
How can I track Beren Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Beren Therapeutics's shares on secondary markets.